Progress report: prophylaxis and therapy for MAC.
Currier
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017963:Azithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D017828:Rifabutin / Q000008:administration & dosage / Q000627:therapeutic use
D000995:Antitubercular Agents; D017828:Rifabutin; D017963:Azithromycin; D004977:Ethambutol; D002991:Clofazimine; D017291:Clarithromycin